INVO Fertility, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
INVO Fertility, Inc. (IVF) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 2.63 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-06-22.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-06-22
- INVO Fertility, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 2.63M shares, a 10007.97% increase year-over-year.
- INVO Fertility, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 25.98K shares, a 93.49% decline year-over-year.
- INVO Fertility, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 398.91K shares, a 32.90% decline year-over-year.
- INVO Fertility, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 594.49K shares, a 65.73% decline year-over-year.
- INVO Fertility, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 1.10M shares, a 14141.14% increase from fiscal 2024.
- INVO Fertility, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 7.72K shares, a 98.09% decline from fiscal 2023.
- INVO Fertility, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 403.54K shares, a 323.18% increase from fiscal 2022.
- INVO Fertility, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 95.36K shares, a 92.75% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 2.63M shares 10-Q · filed 2026-06-22 | |||||||
| 2025-12-31 | 1.10M shares 10-K · filed 2026-06-02 | |||||||
| 2025-09-30 | 1.55M shares 10-Q · filed 2025-11-17 | |||||||
| 2025-06-30 | 1.55M shares 10-Q · filed 2025-08-14 | |||||||
| 2025-03-31 | 25.98K shares 10-Q · filed 2026-06-22 | 3.12M shares 10-Q · filed 2025-05-20 | ||||||
| 2024-12-31 | 7.72K shares 10-K · filed 2026-06-02 | 926.60K shares 10-K · filed 2025-04-30 | ||||||
| 2024-09-30 | 174.87K shares 10-Q · filed 2025-11-17 | 6.30M shares 10-Q · filed 2024-11-19 | ||||||
| 2024-06-30 | 1.63M shares 10-Q · filed 2025-08-14 | 6.65M shares 10-Q · filed 2024-08-14 | ||||||
| 2024-03-31 | 398.91K shares 10-Q · filed 2025-05-20 | 4.79M shares 10-Q · filed 2024-05-15 | ||||||
| 2023-12-31 | 403.54K shares 10-K · filed 2025-04-30 | 4.84M shares 10-K · filed 2024-04-16 | ||||||
| 2023-09-30 | 3.65M shares 10-Q · filed 2024-11-19 | |||||||
| 2023-06-30 | 524.53K shares 10-Q/A · filed 2024-11-19 | |||||||
| 2023-03-31 | 594.49K shares 10-Q · filed 2024-05-15 | 11.89M shares 10-Q · filed 2023-05-15 | ||||||
| 2022-12-31 | 95.36K shares 10-K/A · filed 2024-11-19 | 1.91M shares 10-K · filed 2023-04-17 | ||||||
| 2022-09-30 | 86.99K shares 10-Q · filed 2023-11-13 | 1.74M shares 10-Q · filed 2022-11-14 | ||||||
| 2022-06-30 | 87.49K shares 10-Q · filed 2023-08-14 | 1.75M shares 10-Q · filed 2022-08-15 | ||||||
| 2022-03-31 | 1.73M shares 10-Q · filed 2023-05-15 | |||||||
| 2021-12-31 | 1.32M shares 10-K · filed 2023-04-17 | |||||||
| 2021-09-30 | 1.50M shares 10-Q · filed 2022-11-14 | |||||||
| 2021-06-30 | 1.49M shares 10-Q · filed 2022-08-15 | |||||||
| 2021-03-31 | 1.48M shares 10-Q · filed 2022-05-16 | |||||||
| 2020-12-31 | 1.74M shares 10-K · filed 2022-03-31 | |||||||
| 2020-09-30 | 2.19M shares 10-Q · filed 2021-11-15 | |||||||
| 2020-06-30 | 2.16M shares 10-Q · filed 2021-08-16 | |||||||
| 2019-12-31 | 345.34K shares 10-K · filed 2021-03-30 | 11.05M shares 10-K · filed 2020-03-30 | ||||||
| 2018-12-31 | 6.02M shares 10-K · filed 2020-03-30 | |||||||
| 2017-12-31 | 3.39M shares 10-K · filed 2019-04-16 | |||||||
| 2016-12-31 | 3.43M shares 10-K · filed 2018-03-29 | |||||||
| 2015-12-31 | 3.24M shares 10-K · filed 2017-04-20 | |||||||
| 2014-12-31 | 9.50M shares 10-K · filed 2017-03-17 | |||||||
| 2013-12-31 | 14.46M shares 10-K · filed 2017-03-17 | |||||||
| 2012-12-31 | 14.05M shares 10-K · filed 2017-03-17 | |||||||
| 2011-12-31 | 17.04M shares 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |